A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Mavroudis D, Bolonakis I, Cornet S, Myllaki G, Kanellou P, Kotsakis A, Galanis A, Nikoloudi I, Spyropoulou M, Menez J, Miconnet I, Niniraki M, Cordopatis P, Kosmatopoulos K, Georgoulias V.
Mavroudis D, et al. Among authors: galanis a.
Oncology. 2006;70(4):306-14. doi: 10.1159/000096252. Epub 2006 Oct 12.
Oncology. 2006.
PMID: 17047402
Clinical Trial.